News from Epilepsy Research UK

SUDEP Action and ERUK supporting judicial review of Government to protect epilepsy patients

Posted 20 Feb 2019 in News from Epilepsy Research UK

The Good Law Project has today (19 February) threatened to issue judicial review proceedings on Tuesday 26 February, unless Government cancels powers allowing pharmacists altering prescriptions in the event of medicines shortages. SUDEP Action are supporting this process by providing evidence on the potentially catastrophic impact this could have on those living with epilepsy. They have written to the Department of Health read more

The supply of antiepileptic medication in the event of a ‘no-deal Brexit’

In December of 2018 it became apparent that in the event of serious drug shortages as a result of a ‘no deal Brexit’, the Government had plans to use emergency powers to authorise pharmacists to overrule medical prescriptions. This ‘serious shortage protocol’ caused serious concern amongst a coalition of epilepsy and neurological organisations who are concerned with safeguarding patients. The read more

What would the impact of a no-deal Brexit have on the epilepsy research community in the UK?

We are all of us wondering what the repercussions of a no-deal Brexit would have on our lives but in the following summary, our CEO, Maxine Smeaton spells out a few of the possible effects of a no-deal on the epilepsy research community. We at ERUK, along with other epilepsy charities are committed to maximising support for medical research in read more

Big win for people with epilepsy: epilepsy medications will be exempt from Brexit after coalition intervenes

The Government has pledged to exempt epilepsy patients from its plans for post-Brexit medicine supplies after experts said some people could die. The Department of Health and Social Care is proposing to give pharmacists powers to dispense alternative drugs if those prescribed by GPs are in short supply after Britain leaves the EU. But the heads of Britain’s largest epilepsy read more

The link between stress and seizures: Final Report

In 2014 Professor Stafford Lightman at the University of Bristol was awarded a pilot grant of £29,208 to investigate the link between stress and seizures. The association between stress and seizures is well recognised, however the mechanisms for this relationship are still not understood. Professor Lightman and his team from the University of Bristol and the University of Exeter, focused read more

Nathan Liptrot – why I fundraise for research

Posted 5 Dec 2018 in News from Epilepsy Research UK

Nathan has been an enthusiastic fundraiser for us, so we thought we would find out more about why he has chosen Epilepsy Research UK as his ‘charity of choice’. Why is it that any organisation needs to raise funds? In many cases it is because there is a lack of government funding and even where funding is available, voluntary funding read more

Language Development After Epilepsy Surgery in Children: Final Report

This is the final report for a 2011 project grant for £99,805 awarded to Dr Torsten Baldeweg, Dr Frederique Liegeois, Professor Helen Cross, Dr Peter Rankin, and Professor Faraneh Vargha-Khadem at the Institute of Child Health, University College London.  Approximately one third of children with epilepsy do not respond to treatment with medication, and a proportion of these children may be considered for read more

Genetic & Autoimmune Childhood Epilepsy (GACE) Study: Final Report

This is the final report for a 2013 project grant of £149,481 awarded to Professor Sameer Zuberi at the Royal Hospital for Children in Glasgow. The purpose of this study was to investigate how new genetic testing technologies can improve the diagnosis and treatment of epilepsy. This is the first study of its’ kind, and included all children in Scotland read more

Cutting-edge techniques to explore brain cell activity in epilepsy: Final Report

This is the final report for a 2014 fellowship grant for £211,516 awarded to Dr Rob Wykes at UCL.  Recent technical advances allow optical imaging of neocortical network activity in exquisite detail using rodent models. Dr Wykes at UCL was amongst the first apply this technology to study important questions in the field of epilepsy. Using a cutting-edge technique called read more

What might we see in epilepsy research developments in the coming years?

Dr Vincenzo Marra from the University of Leicester was awarded an Epilepsy Research UK project grant earlier this year to look at how naturally occurring changes in the brain during a seizure could throw light on new therapeutic targets. As Dr Marra explains: “I am interested in how the brain can handle an enormous amount of information with very little read more

Finding brain imaging measures that help to predict memory outcomes in children after epilepsy surgery: Final Report

Posted 22 Nov 2018 in News from Epilepsy Research UK

This is the final report for a 2015 pilot grant for £21,666 awarded to Professor Stefano Seri, Professor Amanda Wood, and Dr Elaine Foley at Aston University.  Epilepsy surgery in children offers the prospect of fewer seizures and improved overall quality of life; however there is a risk that brain regions that are important for cognition (thinking, learning and memory) will read more

How Biomarkers will Transform epilepsy care in the 2020s

We asked Professor Deb Pal, from King’s College London, who was awarded an ERUK pilot grant in this year’s funding round, to give us his view on where the biggest advances will be made in epilepsy research over the next few years.  Here is his response. At my primary school in the 1970s, we had an old lady music teacher read more

Understanding the genetics of mesial temporal lobe epilepsy with hippocampal sclerosis: Final Report

This is the final report for a fellowship grant awarded in 2012 for £249,860 to Dr Mar Matarin at UCL.  Mesial temporal lobe epilepsy with hippocampal sclerosis is the most frequent type of epilepsy in people who do not respond well to medication. This type of epilepsy affects some structures of the brain, particularly the hippocampus which is important for read more

The future of epilepsy research: new personalised treatment options and novel therapeutics.

It is estimated that the first human genome sequenced in 2003 cost almost $1 billion and took four years to complete. Fast-forward fifteen years, and remarkably, genomic technologies have advanced so quickly that DNA sequencing is now a valuable and cost-effective clinical tool. The field of epilepsy research has certainly benefitted from genomics, providing a rapid advance in our understanding read more

A closer look at ……GLUTAMATE

Cells in the brain must communicate with each other to function correctly. They do this using chemical messengers called neurotransmitters. Neurotransmitters travel to neighbouring cells through junctions called synapses. Glutamate is the most common neurotransmitter in the body. Although glutamate is vital for the healthy functioning of the brain, research has found abnormal patterns of glutamate immediately before epileptic seizures. read more

How does stimulation of the senses affect the way epileptic seizures spread across the brain? Final Report

Posted 15 Nov 2018 in News from Epilepsy Research UK

This is the final report from a 2015 project grant for £147,758 awarded to Dr Jason Berwick, Dr Samuel Harris, Professor Ying Zheng, and Professor Theodore Schwartz at the University of Sheffield.  Epileptic seizures can start in a small part of the brain before quickly spreading to others, but very little is known about how or why. Finding where seizures read more

Investigating the mechanisms of depression in temporal lobe epilepsy: Final Report

Posted 12 Nov 2018 in News from Epilepsy Research UK

This is the final report for a 2015 pilot grant for £29,977 awarded to Dr Jackie Foong and Dr Matthias Koepp at the National Hospital for Neurology and Neurosurgery, UCLH.  In this pilot study, Dr Foong and colleagues used brain imaging techniques and psychological tests to investigate how the frontal and temporal areas of the brain work in people with temporal read more

What’s new and exciting in epilepsy research?

We asked Dr Robert Wykes, a translational medicine scientist for his personal perspective.  Here is his response: Despite decades of new anti-epileptic drugs (AEDs) reaching market, the problem of drug refractory epilepsy remains. 25-30% of patients do not respond appropriately to AEDs. However in recent years advances in technology and non-pharmacological approaches are beginning to address this clinical need. We read more

Page 1 of 1012345...10...Last »

News categories